[

covid-19 drug

]
Union defence minister Rajnath Singh hands over to Health minister Harsh Vardhan the newly launched anti-COVID drug 2-DG, developed by DRDO, in New Delhi. (File Photo / PTI)

DRDO's anti-Covid drug 2-DG effective against all Covid-19 strains: Study

By hindustantimes.com | Written by Joydeep Bose
PUBLISHED ON JUN 17, 2021 05:43 AM IST
DRDO's drug against the coronavirus disease (Covid-19), 2-deoxy-D-glucose (2-DG), reduces the multiplicity of the SARS-CoV-2 virus, alleviates cells from infection-induced cytopathic effect (CPE) and cell death, the preliminary study claimed.
With such a rapid means of tackling the SARS-Cov-2 virus transmission, anti-Covid drug Molnupiravir can be a complete gamechanger in India's fight against the coronavirus disease pandemic, said the Indian Institute of Chemical Technology. (Photo via kaan_levin on Twitter)
With such a rapid means of tackling the SARS-Cov-2 virus transmission, anti-Covid drug Molnupiravir can be a complete gamechanger in India's fight against the coronavirus disease pandemic, said the Indian Institute of Chemical Technology. (Photo via kaan_levin on Twitter)

CSIR-IICT ties up with Suven Pharma for new anti-Covid drug Molnupiravir

By hindustantimes.com | Written by Joydeep Bose
PUBLISHED ON JUN 11, 2021 10:14 AM IST
CSIR-IICT said Molnupiravir can completely suppress Covid-19 virus transmission within 24 hours, citing a study published in the journal 'Nature Microbiology'. CSIR-NIIST is also collaborating with Suven Pharma for process technology transfer, a press release detailed.
Human trials of oral drug underway to test effectiveness against Covid-19(Twitter/kaan_levin)
Human trials of oral drug underway to test effectiveness against Covid-19(Twitter/kaan_levin)

Human trials of oral drug underway to test effectiveness against Covid-19

PTI |
UPDATED ON APR 19, 2021 08:20 PM IST
While there are currently only vaccines and no drugs for use against coronavirus, researchers are in the final stage of human trial of orally-administered antiviral drug - Molnupiravir, after it turned out to be effective against Covid-19 in hamsters
Gout drug to be tested as potential Covid-19 treatment by second UK study(Photo by Daniel Schludi on Unsplash)
Gout drug to be tested as potential Covid-19 treatment by second UK study(Photo by Daniel Schludi on Unsplash)

Gout drug to be tested as potential Covid-19 treatment by second UK study

Reuters |
UPDATED ON MAR 03, 2021 08:11 PM IST
After a UK study dubbed Recovery, another study in Britain to test gout medication colchicine as potential Covid-19 treatment
The medicine can be administered to coronavirus patients between the age group of 18 and 75.(BLOOMBERG PHOTO.)
The medicine can be administered to coronavirus patients between the age group of 18 and 75.(BLOOMBERG PHOTO.)

Glenmark’s FabiFlu gets DCGI nod as Covid-19 drug, in stores next week: All you need to know

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar
UPDATED ON JUN 20, 2020 10:44 PM IST
Bringing some relief for Covid-19 patients, even as the country reported an all-time high of 14,516 new coronavirus cases on Saturday, the drug will soon be available in hospitals and stores in a pack of 34 oral tables at moderately affordable prices.
SHARE
Story Saved